RiverGlade Capital: Investment Strategy, Funds, Portfolio Companies, and Firm Profile
1. What Is RiverGlade Capital?
RiverGlade Capital is a healthcare-focused private equity firm founded in 2017 by Garrick Rice and Danny Rosenberg. Based in Chicago, it invests in growth-oriented, lower-middle-market businesses. Its central model is control investing, with selected minority opportunities also included in its published criteria. Both founders previously co-led healthcare services investing at Sterling Partners.
The United States is the principal market represented in the investments discussed here, while the firm states a broader North American market focus. Its activities encompass healthcare services, technology-enabled businesses, products and distribution, and healthcare-related franchise models. Recent investments include senior living management, life sciences training, and home health and hospice services.
Within this directory, RiverGlade fits direct private equity and buyouts, sector-specialist private equity, and lower-middle-market investing, with North America as its geography group. Inclusion in the Umbrex Top 1000 Global Private Equity Firms collection is a research classification, not a performance ranking.
2. RiverGlade Capital at a Glance
- Firm name
- RiverGlade Capital.
- Firm type
- Healthcare-focused, lower-middle-market private equity firm.
- Founded
- 2017, in Chicago.
- Founders
- Garrick Rice and Danny Rosenberg, both currently identified as Managing Partners.
- Headquarters
- Chicago, Illinois, United States; an additional office is listed in Vero Beach, Florida.
- Parent organization
- No parent affiliation established in the reviewed materials. Sterling Partners was the founders’ previous employer, not an identified parent.
- Main investment markets
- United States in the selected investment record; broader published focus on North America.
- Geography group
- North America.
- Directory segments
- Direct private equity and buyouts; control buyouts; sector-specialist private equity; lower-middle-market investors.
- Principal strategies
- Healthcare investing supported by organic growth, acquisitions, geographic expansion, and operating development.
- Ownership preference
- Control investments and selected minority opportunities.
- Typical company profile
- Founder-owned businesses with proven growth, differentiated offerings, and a culture of compliance and clinical excellence.
- Sector focus
- Outsourced healthcare services, healthcare technology, and products, equipment, and distribution.
- Important publicly identifiable funds
- RiverGlade Capital, L.P., and Fund II; their verified final closes occurred in 2019 and 2022.
- Current status
- Operating, with transaction activity announced as recently as October 7, 2026.
- Official website
- RiverGlade Capital Official Website
3. Who Founded RiverGlade Capital, and How Is the Firm Organized?
Garrick Rice and Danny Rosenberg co-founded RiverGlade in 2017 after working together at Sterling Partners, where they co-led healthcare services investing. Their experience predates RiverGlade: Rice’s biography dates his principal-investing career to 2001, while Rosenberg’s dates his to 1999. Rice also worked in lending, investment banking, and corporate finance; Rosenberg’s earlier investment banking work focused on healthcare transactions and equity offerings.
Both remain listed as Managing Partners. Dan Skowronski was promoted to Partner on October 28, 2025, and joined the Investment Committee in connection with that promotion. His earlier employers included The Edgewater Funds and Swander Pace Capital. The current organization also identifies investment professionals, finance and compliance leadership, and a Portfolio Operations group.
RiverGlade distinguishes its Portfolio Operations personnel from Executive Partners and the Executive Healthcare Advisory Council. The latter resources contribute industry expertise and portfolio support, but they should not all be understood as employees. The firm describes Executive Partners as retained, compensated non-employee consultants, while council members may be independent contractors or employees of current or former portfolio companies.
This profile concerns RiverGlade’s firm-level investment activities, not the entire investment history of its founders. Investments made during their previous employment are relevant to experience but are not automatically RiverGlade-owned assets.
4. What Is the History of RiverGlade Capital?
2017: Establishment and an early platform investment. Rice and Rosenberg established RiverGlade after their healthcare investing careers at Sterling Partners. In the same year, RiverGlade and the Thurston Group formed U.S. Oral Surgery Management, creating a management-services platform for oral surgery practices. This early transaction demonstrates that the firm’s history includes building platforms with other investors, not only purchasing established standalone companies.
2019: Inaugural institutional fund close. On October 17, 2019, RiverGlade announced the closing of RiverGlade Capital, L.P., with $325 million in capital commitments, exceeding its $300 million target. The announcement established a dedicated pool of institutional capital for the firm’s healthcare strategy. The commitments were a fundraise, not a measurement of investment returns or portfolio value.
2021: Portfolio development and a control-stake sale. RiverGlade acquired Home Helpers from Linsalata Capital Partners. Separately, on November 19, 2021, it announced the sale of its controlling stake in U.S. Oral Surgery Management to Oak Hill Capital. The latter disclosure establishes a sale of control, but does not alone establish whether every affiliated vehicle completely exited.
2022: Second institutional fund. RiverGlade announced Fund II’s close on August 22, 2022, with $453 million of total capital commitments. This followed the inaugural fund rather than introducing a separately described non-healthcare investment business.
2024 and 2025: Additional service platforms. The firm formed a partnership with James River Home Health and Hospice in June 2024 and with Custom Learning Designs in July 2025. These transactions added exposure to home-based clinical care and outsourced commercial training for life sciences companies.
2026: Senior living management and franchise platform formation. An August partnership with Senior Living Residences was followed by the October formation of Sentinel Care Group with Brian Petranick. These developments expanded the documented range of operating models within the firm’s healthcare-related investment activities.
5. What Investment Strategies Does RiverGlade Capital Pursue?
RiverGlade describes its central strategy as control buyouts of growth-oriented, lower-middle-market healthcare companies. Its published criteria also allow selected minority investments. The distinction matters: a preference for control does not mean every transaction involves acquiring all equity, and an investment alongside a founder does not necessarily indicate a separate growth-equity fund.
The firm’s stated growth approach combines organic expansion, acquisitions, and geographic or channel development. It looks for businesses that already demonstrate growth and offer more than one route to value creation. Technology investment and talent development are described as supporting mechanisms, rather than as standalone investment strategies.
Its transaction record contains several distinct situations. Home Helpers was purchased from another financial sponsor. James River’s partnership retained its founder as CEO. Custom Learning Designs involved an established owner-manager who continued leading the business. Senior Living Residences combined management continuity with its founder’s transition to the board. These examples support a flexible approach to ownership transitions within a focused healthcare mandate.
Sentinel Care Group illustrates a different route: formation of a platform with an experienced executive to acquire, partner with, or develop franchise businesses. That is not the same transaction type as buying an existing operating company. Analytically, the common thread across these approaches is platform development, with the ownership structure adapted to the particular business and its leadership.
6. What Funds Does RiverGlade Capital Manage?
Two important flagship healthcare funds are publicly identifiable from verified final-close announcements. Their disclosed amounts are capital commitments, not assets under management, invested capital, or net asset value.
- RiverGlade Capital, L.P., commonly identified as Fund I
- The inaugural fund closed with $325 million in commitments, announced on October 17, 2019. Its stated fundraising target was $300 million. A subsequent company announcement expressly identified Dynamic Access as a Fund I portfolio company in June 2024.
- RiverGlade Capital Fund II, LP
- The firm announced Fund II’s close on August 22, 2022, with $453 million of total capital commitments. This is the most recent final-close announcement verified for this profile. It is not a statement that Fund II remains within its original investment period in October 2026.
The identifiable flagship structure is therefore a succession of healthcare private-equity limited partnerships. This profile does not establish the complete legal architecture of every parallel, feeder, co-investment, or holding vehicle. Nor does it verify a separately branded continuation, evergreen, venture, or credit fund.
Company-level fund attribution requires separate evidence. Dynamic Access’s disclosed Fund I relationship cannot be used to assign James River, or any other investment, to a fund by chronology. Where the underlying fund has not been verified, the portfolio table identifies the supported strategy instead. Current fund-level capital availability, investor economics, and remaining investment capacity are not established here.
7. What Types of Companies Does RiverGlade Capital Invest In?
RiverGlade’s published criteria, reviewed on October 13, 2026, identify target enterprise values of $15 million to $300 million and equity investments of $15 million to $100 million per platform. They specify up to $20 million of EBITDA for platform investments and no minimum for add-ons. These are different measures: enterprise value describes the business’s valuation, while the equity range describes the contemplated investment.
The qualitative profile emphasizes founder ownership, demonstrated organic growth, a differentiated offering, and compliance and clinical standards. These characteristics are selection criteria described by the firm, not independently established attributes of every portfolio business.
The selected transactions show that RiverGlade is not limited to one ownership situation. Home Helpers provides a sponsor-to-sponsor acquisition example. James River provides a founder partnership example. Senior Living Residences demonstrates a transition in which the founder moved to the board while the existing CEO and management team continued operating the company.
Custom Learning Designs adds an established, technology-enabled business serving pharmaceutical, biotechnology, and medical device customers. Its investment announcement describes both expansion within existing client relationships and potential acquisitions. Those were identified growth opportunities, not a disclosure that all such initiatives had already been completed.
Analytically, these examples suggest a focus on businesses whose existing operating model can be expanded. A dominant carve-out or public-to-private strategy is not established by the transactions selected for this profile.
8. Which Industries Does RiverGlade Capital Focus On?
Healthcare is RiverGlade’s organizing investment theme, but its exposure extends beyond direct medical treatment. Its published areas of interest include outsourced services, healthcare technology, and products, equipment, and distribution. These stated interests should be distinguished from sectors in which a completed investment has been verified.
Post-acute and home health. James River provides home health and hospice services, while Home Helpers is a home-care franchisor. The two investments address related care needs through different business models: an operating care provider and a franchise system.
Dental service organizations. RiverGlade’s history includes U.S. Oral Surgery Management, a management-services business supporting oral surgery practices. The firm also publicly identifies Kids Care Dental among its investments. These are service and practice-support exposures, not evidence of a dental-products manufacturing specialization.
Veterinary services. CityVet is publicly identified as an investment and is described as a network of veterinary practices offering medical and related pet-care services. This provides documented animal-health service exposure within RiverGlade’s broader healthcare investment history.
Other documented operating models include senior living management through Senior Living Residences and outsourced life sciences sales training through Custom Learning Designs. The former manages communities for property owners; the latter develops training solutions for commercial teams. Neither should be confused with direct ownership of healthcare real estate or investment in drug development.
9. Where Does RiverGlade Capital Invest?
RiverGlade is headquartered in Chicago, in the United States. Its contact information also identifies a Vero Beach, Florida office. Office locations describe the organization’s presence, not the boundaries of its investment mandate.
The firm publishes a North American market focus. The selected transactions in this profile provide a specifically U.S. investment record, including businesses based in Massachusetts, Virginia, Texas, and Ohio. That supports the United States as a principal market without reducing the stated mandate to the Chicago area or to a single state.
Portfolio companies may have broader operating footprints than their headquarters suggest. Senior Living Residences’ August 2026 announcement described communities across several Northeastern states. James River’s December 2025 partnership with Golden Rule Hospice extended its documented activity from Virginia into Georgia. Dynamic Access entered Minnesota through its March 2026 acquisition of PICC Stat.
These examples show geographic expansion within operating platforms. They do not establish a separate international fund, and portfolio expansion should not be confused with the opening of a RiverGlade office. For directory purposes, North America is the appropriate geography group. A substantial non-North-American investment mandate is not verified in the materials retained for this profile.
10. How Does RiverGlade Capital Seek to Create Value?
RiverGlade’s operating resources include a Portfolio Operations group. Mitch Bloomberg and Nick Wisniewski are identified as Vice Presidents of Portfolio Operations, with responsibilities for helping portfolio companies improve performance and lead strategic initiatives. Their biographies describe finance and operating experience, including roles within private-equity-backed businesses.
The Executive Healthcare Advisory Council supplies a different resource: operational guidance, strategic advice, reimbursement and regulatory expertise, industry relationships, and board participation. Council members also assist with investment sourcing, diligence, investment theses, and identifying talent. These are documented available capabilities, not evidence that every member works with every portfolio company.
Individual transactions show how support can be applied. At James River, RiverGlade recruited council member Tim Boes to the board. The investment announcement identified new locations and tuck-in acquisitions as potential expansion routes, supported by the company’s existing admission, staffing, and referral processes. These were described opportunities, not quantified achieved benefits.
Dynamic Access provides a documented acquisition example. Its March 2026 purchase of PICC Stat added Minnesota as a market. The announcement described additional clinical, operational, and technology resources for the acquired business, while emphasizing continuity of service. It did not publish a quantified integration saving or investment-return result.
Analytically, RiverGlade’s model combines investment oversight, operating assistance, and specialist industry relationships. The reviewed evidence does not establish a separately branded AI program, portfolio-wide technology deployment, or quantified firm-wide operating results. Those capabilities and outcomes should not be inferred from a general commitment to efficiency.
11. What Types of Business Situations May Fit RiverGlade Capital?
The following situations are analytical interpretations of RiverGlade’s documented criteria and transactions. They describe strategic consistency, not transaction eligibility, current appetite for a particular company, or investment advice.
A founder seeking expansion capital and additional operating resources. James River illustrates a partnership in which the founder continued as CEO while the firm added board-level expertise and identified expansion opportunities.
An ownership transition with management continuity. At Senior Living Residences, the founder moved to the board while the CEO and existing management team continued leading operations. This supports a transition model that separates shareholder change from wholesale management replacement.
An established outsourced-services business with room to broaden its offering. Custom Learning Designs’ partnership announcement identified deeper client relationships and acquisitions as potential growth routes. This is consistent with expanding a proven service platform rather than financing an unproven product alone.
A healthcare-related franchise business or platform. Home Helpers demonstrates an acquisition of an existing franchisor. Sentinel demonstrates executive-led platform formation, with acquisitions, partnerships, and new concepts contemplated as development routes.
Published size and ownership criteria provide additional context, but the evidence does not support treating them as automatic approval rules. Each actual investment would require transaction-specific assessment.
12. What Distinguishes RiverGlade Capital?
Four characteristics help explain RiverGlade’s investment proposition without implying superiority over other investors.
A healthcare investing background that predates the firm. Rice and Rosenberg previously co-led healthcare services investing at Sterling Partners. Their experience is relevant to RiverGlade’s specialization, but predecessor investment results should not be presented as returns earned by RiverGlade funds.
Multiple operating models within one broad sector. The selected investments include clinical services, senior living management, outsourced life sciences training, and franchising. RiverGlade is therefore more accurately described as a healthcare specialist than as an investor in only one clinical specialty.
Distinct operating and advisory resources. Portfolio Operations personnel provide company support, while Executive Partners and council members contribute additional expertise through different relationships. This distinction is important when evaluating the resources directly employed by the firm versus those accessed through advisers.
Ownership change can coexist with leadership continuity. James River, Custom Learning Designs, and Senior Living Residences each provide a documented example of existing leadership remaining involved after RiverGlade’s partnership. That is an observed transaction pattern, not a promise of identical terms for future sellers.
These characteristics describe the model and its implementation. They do not establish superior returns, lower investment risk, or suitability for a particular company.
13. How Should RiverGlade Capital Be Understood Today?
As reviewed on October 13, 2026, RiverGlade remains centered on lower-middle-market healthcare investing. Its public positioning emphasizes helping businesses grow and scale, rather than operating as a diversified manager across unrelated private-market asset classes. The verified material supports a healthcare-specialist classification; it does not establish separate infrastructure, real estate, or private-credit businesses.
The recent transaction record shows a broader range of healthcare-related operating businesses. Senior Living Residences adds third-party community management, while Sentinel adds a newly formed franchise-development platform. These are different approaches to company formation and ownership, but neither establishes a wholesale change away from the firm’s stated healthcare focus.
The organization has also developed beyond its founding partnership. Dan Skowronski’s October 2025 promotion added a Partner and Investment Committee member, while the current team includes dedicated Portfolio Operations roles. That is evidence of organizational development, not a basis for assuming a particular staffing ratio or level of involvement at every company.
Important limitations remain. Fund II’s verified final-close amount is $453 million as announced in August 2022, not a new October 2026 AUM figure. Company-level fund assignments and residual ownership are not uniformly established. The portfolio selection therefore preserves those distinctions rather than claiming complete, contemporaneously measured coverage of every investment.
14. Frequently Asked Questions
Who founded RiverGlade Capital?
Garrick Rice and Danny Rosenberg co-founded RiverGlade in 2017. Both previously co-led healthcare services investing at Sterling Partners and remain identified as Managing Partners. Their earlier investing experience predates the creation of RiverGlade.
Where is RiverGlade headquartered, and where does it invest?
RiverGlade is headquartered in Chicago and also lists a Vero Beach office. Its published investment focus is North America, while the selected company transactions in this profile are U.S.-based. Headquarters and investment geography should not be treated as equivalent.
What company size does RiverGlade target?
Its published criteria identify enterprise values of $15 million to $300 million and platform equity investments of $15 million to $100 million. These are target transaction parameters, not fund sizes or evidence that every completed investment falls within identical limits.
Does RiverGlade invest only in control buyouts?
No. Control investing is central to its stated model, but its criteria also permit selected minority opportunities. The actual ownership structure must be verified for each transaction; founder participation alone does not establish whether RiverGlade holds a majority or minority stake.
Which major funds are publicly identifiable?
The inaugural RiverGlade Capital, L.P., closed with $325 million in commitments in October 2019. Fund II closed with $453 million in total commitments in August 2022. These disclosed fundraise amounts should not be combined and presented as current AUM.
Did RiverGlade completely exit U.S. Oral Surgery Management?
RiverGlade announced the sale of its controlling stake to Oak Hill on November 19, 2021. That establishes a control-stake exit. Complete elimination of every affiliated residual holding was not verified, so the table uses Status unclear rather than asserting a full exit.
Does inclusion in the Top 1000 collection indicate superior performance?
No. Top 1000 identifies the Umbrex research collection. Inclusion does not establish superior returns, investment quality, prestige, fundraising strength, current investment appetite, or suitability for a particular company. RiverGlade’s profile should be read as a description of its documented activities.